Sort by
Refine Your Search
-
Category
-
Program
-
Employer
-
Field
-
theoretical research efforts in a friendly and inclusive environment with state-of-the-art infrastructure. The ESRF, the European Synchrotron , is an international research facility based in Grenoble, France
-
Professor Dr. Rama Gottfried at the Institute of Computer Music and Sound Technology (ICST) at the Zurich University of the Arts (ZHdK). Project background The project aims to develop theoretical and
-
experiments or observations, mathematical modelling, and state-of-the-art tools (e.g., genomics, phenotyping, eDNA), would be a perfect fit for the position. The future professor is invited to take advantage
-
skills in English. What we offer: You will be part of a team of academic researchers working on state of the art technologies for machine learning and computer vision. You will have the chance to
-
primarily be linked to a state-of-the-art project examining the neurophysiological mechanisms of cognitive task performance in adults. The internship will begin in the summer 2024, or September at the latest
-
We offer An exciting applied research project with clear connections to sustainable industrial developments Access to state of the art facilities and instrumentation at ETH Zurich Training
-
velocity, gravity). Leveraging your expertise and modeling insights, your innovative thinking extends the state-of-the-art of geothermal energy production and CO2 / H2 storage technologies. Profile We seek a
-
validation. By combining state-of-the-art engineering approaches and new cellular models, this project is aimed at realizing new kidney models, which will find application in both fundamental biology and drug
-
conferences State-of-the-art experimental and computational infrastructure Working, teaching and research at ETH Zurich We value diversity In line with our values , ETH Zurich encourages an inclusive culture
-
background Our group uses state-of-the-art Synthetic Biology principles to engineer human cells and develop cell-based therapies for the treatment of cancer as well as metabolic, neurodegenerative, autoimmune